Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Liabilities and Shareholders Equity (2020 - 2025)

Bio Essence has reported Liabilities and Shareholders Equity over the past 6 years, most recently at $422474.0 for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $422474.0 for Q4 2025, up 50.33% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (down 79.7% YoY), and the annual figure for FY2025 was $422474.0, up 50.33%.
  • Liabilities and Shareholders Equity for Q4 2025 was $422474.0 at Bio Essence, up from $184534.0 in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for BIOE hit a ceiling of $2.8 million in Q4 2023 and a floor of $112692.0 in Q2 2025.
  • Median Liabilities and Shareholders Equity over the past 5 years was $1.7 million (2021), compared with a mean of $1.4 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 78.23% in 2023 and later plummeted 94.62% in 2025.
  • Bio Essence's Liabilities and Shareholders Equity stood at $1.7 million in 2021, then decreased by 8.92% to $1.5 million in 2022, then skyrocketed by 78.23% to $2.8 million in 2023, then plummeted by 89.81% to $281024.0 in 2024, then surged by 50.33% to $422474.0 in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $422474.0 (Q4 2025), $184534.0 (Q3 2025), and $112692.0 (Q2 2025) per Business Quant data.